Archives
From Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
From Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Background:
Health literacy is defined by the Institute of Medicine as the degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make informed health decisions.1 Low health literacy affects 25% of patients with CKD and is associated with increased morbidity and death.2 The annual global incidence of IgA nephropathy (IgAN) is 2.5 cases/100,000; however this varies by region and ethnicity.3 The annual US incidence is around 1.29/100,000 persons.4
Did You Know?
- Nearly 9 in 10 adults in America have trouble understanding some or all the health information they receive from HCPs or publicly.5
- Many patients with IgAN have lost nearly 50% of their kidney function at the time of diagnosis.6
Why Attend This Webinar?
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss some of the challenges in her own practice. We will discuss how differing levels of health literacy can impact the patient journey during presentation, diagnosis, prognosis, and management, including access to care.
What You Will Learn
- What is health literacy and how it relates to kidney disease and the patient journey in IgAN.
- Clinical features, diagnosis, and prognosis of IgAN and how differing levels health literacy can impact patient outcomes.
- How healthcare professionals can support patients with differing levels of health literacy.
References:
- Jain D, et al. World J Nephrol. 2016;5(2):147-151.
- Campbell ZC, et al. Cochrane Database Syst Rev. 2022;12(12):CD012026. March 2025 US.CORP.X.25.00051
- McGrogan A et al. Nephrol Dial Transplant. 2011 ;26(2) :414-430
- Kwon CS et al. J Health Econ Outcomes Res. 2021;8(2):36-45
- US Department of Health and Human Services (DHHS), Office of Disease Prevention and Health Promotion. National action plan to improve health literacy. Washington, DC: Author. https://odphp.health.gov/sites/default/files/2019-09/Health_Literacy_Action_Plan.pdf. Published 2010. Assessed 3/18/25
- Kwon CS, et al. J Health Econ Outcomes Res. 2021;8(2):36-45
Speakers
Maria-Gabriela Velez, MD, PhD
her medical training and obtained her doctorate in immunology at the University of Colorado School of Medicine. She then completed her training in internal medicine and her fellowship in nephrology at Stanford University and later joined Kidney Associates of Colorado in 2015.
Moderators
Lisa Voigt, PharmD, BCPS, BCCCP
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Senior Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
Maria-Gabriela Velez, MD, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Lisa Voigt, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional.
